0.5164
Enzo Biochem Inc (ENZ) 最新ニュース
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc.'s (NYSE:ENZ) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem stock hits 52-week low at $0.51 amid challenges - MSN
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024 - MSN
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Neuroscience Antibodies and Assays Market to Grow by USD 2.20 Billion from 2024-2028, Rising Neurological Disorders Boost Growth, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve
StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges - Investing.com Canada
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem settles class action for $7.5 million - MSN
Enzo Biochem settles class action for $7.5 million By Investing.com - Investing.com Australia
Enzo Biochem shareholders elect board, approve executive pay - Investing.com India
Enzo Biochem shareholders elect board, approve executive pay By Investing.com - Investing.com UK
Enzo Biochem’s Strategy to Resolve NYSE Compliance Issues - Zenopa
Enzo Biochem Agrees to Settlement in Class Action Suit Related to Ransomware Attack - Defense World
Enzo Biochem to Pay $7.5 Million to Settle Suit Over 2023 Breach - Bloomberg Law
Enzo Biochem Receives Notice from NYSE Regarding Listing ComplianceFarmingdale, NY – Enzo Biochem, Inc. (NYSE: ENZ) recently disclosed that it received a notice from the New York Stock Exchange (NYSE) indicating non-compliance with certain listing - Defense World
Enzo Biochem faces NYSE compliance challenges By Investing.com - Investing.com Canada
Enzo Biochem faces NYSE compliance challenges - Investing.com
Enzo Biochem Faces NYSE Compliance Challenges - TipRanks
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules - The Manila Times
Enzo Biochem Receives NYSE Non-Compliance Notice Over Market Cap and Share Price Issues - StockTitan
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges - MSN
Enzo Biochem (NYSE:ENZ) versus Grail (NASDAQ:GRAL) Financial Review - Defense World
Enzo Biochem stock hits 52-week low at $0.68 amid challenges - Investing.com Nigeria
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Enzo Biochem (ENZ) Stock Surges 5.19% Amid Market Activity - GuruFocus.com
大文字化:
|
ボリューム (24 時間):